Friday, December 2, 2022
HomeFactsBreast Cancer Research And Treatment Impact Factor

Breast Cancer Research And Treatment Impact Factor

Advances In Breast Cancer Research

New research looks at quality of life impact from breast cancer surgery

A polyploid giant cancer cell from triple-negative breast cancer.

NCI-funded researchers are working to advance our understanding of how to prevent, detect, and treat breast cancer. They are also looking at how to address disparities and improve quality of life for survivors of the disease.

This page highlights some of the latest research in breast cancer, including clinical advances that may soon translate into improved care, NCI-supported programs that are fueling progress, and research findings from recent studies.

Tcr 2020 Annual Report

Greetings from Editor-in-Chief and Editorial Office of Translational Cancer Research!

We are pleased to share the 2020 Annual Report of Translational Cancer Research here. 2020 has seen much progress for TCR. We hope 2021 will bring greater things to TCR. We would like to thank you for your support and assistance in improving the journal over the past year, and we certainly look forward to your innovations and contributions in 2021.

We would especially like to express our sincere gratitude to the editorial board members, guest editors, reviewers, authors and readers for all your support and contributions to TCR. We wish you a happy, healthy and prosperous 2021!

Breast Cancer Research And Treatment Impact Score 2021

The impact score 2021 of Breast Cancer Research and Treatment is 4.06, which is computed in 2022 as per its definition.Breast Cancer Research and Treatment IS is by a factor of 0.04 and approximate percentage change is -0.98% when compared to preceding year 2020, whichshows a falling trend.The impact score , also denoted as Journal impact score , of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

You May Like: Is Triple Negative Breast Cancer Deadly

Celts Germanic Tribes And Romans

From 800 BC onwards, the Celtic became influential, replacing the . Iron ore brought a measure of prosperity and was available throughout the country, including . travelled from settlement to settlement with bronze and iron, fabricating tools on demand. The was found in a burial mound, the largest of its kind in western Europe and containing an iron sword with an inlay of gold and coral.

The deteriorating climate in Scandinavia around 850 BC further deteriorated around 650 BC and might have triggered migration of tribes from the North. By the time this migration was complete, around 250 BC, a few general cultural and linguistic groups had emerged. The inhabited the northern part of the . They would later develop into the and the early . A second grouping, the , extended along the middle Rhine and and inhabited the Low Countries south of the great rivers. This group consisted of tribes that would eventually develop into the . Also the had expanded over a wide range, including the southern area of the . Some scholars have speculated that even a third ethnic identity and language, neither Germanic nor Celtic, survived in the Netherlands until the Roman period, the Iron Age culture, that eventually was absorbed by the to the south and the Germanic peoples from the east.

Iii Other Science Influence Indicators

World Cancer Day 2021: Spotlight on IARC research related to breast ...

Any impact factor or scientometric indicator alone will not give you the full picture of a science journal. There are also other factors such as H-Index, Self-Citation Ratio, SJR, SNIP, etc. Researchers may also consider the practical aspect of a journal such as publication fees, acceptance rate, review speed.

Also Check: Can Clinical Exams Detect Breast Cancer

Breast Cancer: Targets And Therapy

Editor-in-Chief: Professor Pranela Rameshwar

Breast Cancer: Targets and Therapy is an international, peer reviewed, open access journal focusing on breast cancer, basic and translational research, clinical trials and treatment. The latter includes outcome studies that incorporate preventative and integrated treatment strategies for enhanced survival, and quality of life for cancer patients.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics .

– 5 records –

Published Date: 19 September 2022

Published Date: 8 September 2022

Published Date: 2 September 2022

Published Date: 26 August 2022

Contact Us Privacy Policy

Dove Press Ltd software development by maffey.com Web Design by Adhesion

The opinions expressed in all articles published here are those of the specific author, and do not necessarily reflect the views of Dove Medical Press Ltd or any of its employees.

Dove Medical Press is part of Taylor & Francis Group, the Academic Publishing Division of Informa PLCCopyright 2017 Informa PLC. All rights reserved. This site is owned and operated by Informa PLC whose registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36

If you agree to our use of cookies and the contents of our Privacy Policy please click ‘accept’.

Breast Cancer Research And Treatment Publisher

Breast Cancer Research and Treatment is published by Springer New York. It’s publishing house is located in United States.Coverage history of this journal is as following: 1981-2021.The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.

Don’t Miss: How To Look For Breast Cancer

Managing Cancer Drug Resistance From The Perspective Of Inflammation

The development of multidrug resistance in cancer chemotherapy is a major obstacle to the effective treatment of human malignant tumors. Several epidemiological studies have demonstrated that inflammation is closely related to cancer and plays a key role in the development of both solid and liquid tumors. Therefore, targeting inflammation and the molecules involved in the inflammatory process may be a good strategy for treating drug-resistant tumors. In this review, we discuss the molecular mechanisms underlying inflammation in regulating anticancer drug resistance by modulating drug action and drug-mediated cell death pathways. Inflammation alters the effectiveness of drugs through modulation of the expression of multidrug efflux transporters and drug-metabolizing enzymes . In addition, inflammation can protect cancer cells from drug-mediated cell death by regulating DNA damage repair, downstream adaptive response , and tumor microenvironment. Intriguingly, manipulating inflammation may affect drug resistance through various molecular mechanisms validated by in vitro/in vivo models. In this review, we aim to summarize the underlying molecular mechanisms that inflammation participates in cancer drug resistance and discuss the potential clinical strategies targeting inflammation to overcome drug resistance.

New Impact Factor For Translational Cancer Research: 0496

Breast cancer awareness month: Addressing risk factors could prevent up to 30% of cases

We are pleased to announce that the Translational Cancer Research has attained its latest impact factor update for the 2021 citation year: 0.496.

We strive to follow the best practices in publishing. Here, we would like to extend our heartfelt gratitude to all our Editorial Team Members, Guest Editors, authors, and reviewers for their significant contributions.

Also Check: Does Breast Cancer Have Any Symptoms

Translational Cancer Research Is Indexed In Pubmed/pmc: A Tremendous Step Forward

We are delighted to announce that Translational Cancer Research has passed the Scientific Quality Review by NLM for PMC. TCR is now indexed in PubMed/PMC, two important and extensive biomedical digital databases, which means publications in TCR will enjoy maximum exposure. All articles published in TCR from 2019 onwards will be available in PubMed/PMC within 1-2 months.

Reviewer Of The Month

In 2022, TCR reviewers continue to make outstanding contributions to the peer review process. They demonstrated professional effort and enthusiasm in their reviews and provided comments that genuinely help the authors to enhance their work.

Hereby, we would like to highlight some of our outstanding reviewers, with a brief interview of their thoughts and insights as a reviewer. Allow us to express our heartfelt gratitude for their tremendous effort and valuable contributions to the scientific process.

Don’t Miss: Can I Get Breast Cancer At 15

Synergy In Action: Novel Approaches To Combining Radiation Therapy And Immunotherapy

We are pleased to have multiple experts of their respective fields review and discuss the current literature and ongoing trials combining RT and immunotherapy. After reading our edition, I hope you have a better overview of where the oncology field is heading and how together with both RT and immunotherapy, we can continue our efforts to treat and potentially cure our patients with cancer.

Supplement On Multicancer Early Detection

Breast cancer survival among young women: a review of the role of ...

To expedite the development and application of potentially transformative multicancer early detection assays, an international summit was hosted by the Mayo Clinic Cancer Center, the American Cancer Society, and the Union for International Cancer Control on World Cancer Day 2020. Insights shared during this unique summit have been formulated into a series of expert-authored commentaries.

You May Like: How Long After Breast Cancer Surgery Does Radiation Start

Breast Cancer Research And Treatment Indexing

The Breast Cancer Research and Treatment is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded , Social Sciences Citation Index , Arts & Humanities Citation Index , and Emerging Sources Citation Index .

Aims & Scope Of The Journal

Breast Cancer Research and Treatment publishes academic articles exploring novel crucial contributions in the areas of Oncology and Cancer Research. The primary research topics disseminated in this academic venue consist of Internal medicine, Oncology, Cancer, Cancer research and Endocrinology. Breast Cancer Research and Treatment provides high-quality, original documents where all submitted papers are peer reviewed to assure top quality. The journal welcomes submissions from the research community where emphasis will be placed on the originality and the practical significance of the published findings.Breast Cancer Research and Treatment is covered by a variety abstracting/indexing services including Scopus, Journal Citation Reports and Research.com. A number of renowned researchers considered this journal to publish their scholarly documents including Steven A. Narod, Steven A. Narod, Emad A. Rakha, Emad A. Rakha and Rulla M. Tamimi.For extra details on the instructions and submission requirements for authors, you are advised to see the journal website for Breast Cancer Research and Treatment at .

Read Also: Survival Rate Of Triple Negative Breast Cancer

Batavian Republic And Kingdom

With the armed support of , proclaimed the , modelled after the and rendering the Netherlands a on 19 January 1795. The had fled to England. But from 1806 to 1810, the was set up by as a puppet kingdom governed by his brother to control the Netherlands more effectively. However, King Louis Bonaparte tried to serve Dutch interests instead of his brother’s, and he was forced to abdicate on 1 July 1810. The Emperor sent in an army and the Netherlands until the autumn of 1813 when Napoleon was defeated in the .

, son of the last stadtholder, returned to the Netherlands in 1813 and proclaimed himself . Two years later, the added the southern Netherlands to the north to create a strong country on the northern border of France. William Frederick raised this to the status of a kingdom and proclaimed himself as in 1815. In addition, William became hereditary in exchange for his German possessions. However, the Southern Netherlands had been culturally separate from the north since 1581, and . The south gained independence in 1830 as Belgium , while the between Luxembourg and the Netherlands was severed in 1890, when died with no surviving male heirs. prevented his daughter from becoming the next Grand Duchess.

The Netherlands abolished slavery in its colonies in 1863. Enslaved people in would be fully free only in 1873, since the law stipulated that there was to be a mandatory 10-year transition.

Art Architecture And Philosophy

Updating Breast Cancer Risk Factors

Literature flourished as well during the Dutch Golden Age, with and as the most famous writers. In the 19th century, wrote about the poor treatment of the natives in the Dutch colony. by is the most translated book from Dutch. Other important 20th century authors include , , , , and . wrote successful detectives, and children’s books.

Various architectural styles can be distinguished in the Netherlands. The was built between the years 950 and 1250. This architectural style is most concentrated in the provinces of and . The was used in the Netherlands from about 1230. Gothic buildings had large windows, pointed arches and were richly decorated. originated with the rise of the Duchy of Brabant and spread throughout the Burgundian provinces. and classicism is especially evident in the west of the Netherlands. Other common architectural styles are , , , , , , and .

and were famous Dutch philosophers. The Dutch scientist discovered ‘s moon , argued that light travelled as waves, invented the , and was the first physicist to use mathematical formulae. was the first to observe and describe with a .

, , , cheese, pottery, and have grown to symbolize the Netherlands, especially among tourists.

Recommended Reading: What Genes Are Tested For Breast Cancer

A Decade Later: The State Of Patient Navigation In Cancer

The American Cancer Society is committed to advancing patient navigation efforts that eliminate barriers to quality cancer care, reduce disparities in health outcomes, and foster ongoing health equity. Learn more about the latest efforts in patient navigation in this 2022 research roadmap from Cancer.

Early Detection And Treatment Research

The Breast Specialized Programs of Research Excellence are designed to quickly move basic scientific findings into clinical settings. The Breast SPOREs support the development of new therapies and technologies, and studies to better understand tumor resistance, diagnosis, prognosis, screening, prevention, and treatment of breast cancer.

The NCI Cancer Intervention and Surveillance Modeling Network focuses on using modeling to improve our understanding of how prevention, early detection, screening, and treatment affect breast cancer outcomes.

The Confluence Project, from NCI’s Division of Cancer Epidemiology and Genetics , is developing a research resource that includes data from thousands of breast cancer patients and controls of different races and ethnicities. This resource will be used to identify genes that are associated with breast cancer risk, prognosis, subtypes, response to treatment, and second breast cancers.

The goal of the Breast Cancer Surveillance Consortium , an NCI-funded program launched in 1994, is to enhance the understanding of breast cancer screening practices in the United States and their impact on the breast cancer’s stage at diagnosis, survival rates, and mortality.

There are ongoing programs at NCI that support prevention and early detection research in different cancers, including breast cancer. Examples include:

Read Also: Is Breast Cancer Considered Internal Cancer

Netherlands And The Low Countries

The region called the have the same . Place names with Neder, Nieder, Nedre, Nether, Lage or Low and Bas or Inferior are in use in low-lying places all over Europe. In the case of the Low Countries / Netherlands the geographical location of the lower region has been more or less downstream and near the sea. The made a distinction between the Roman provinces of downstream and upstream . The designation ‘Low’ returned in the 10th-century Duchy of , that covered much of the Low Countries.

The used the term les pays de par deçà for the Low Countries. Under , Les pays de par deçà developed in pays d’embas . This was translated as Neder-landen in contemporary Dutch official documents. From a regional point of view, Niderlant was also the area between the and the lower in the late Middle Ages. From the mid-sixteenth century, the “Low Countries” and the “Netherlands” lost their original . The divided the Low Countries into an independent northern and a Spanish-controlled .

In most , the term “Low Countries” is used as the name for the Netherlands. In other languages, it is sometimes used to describe the countries.

Breast Cancer Research And Treatment

Figure 1 from Hypoxia

Why publish with us

  • For more than 35 years, our journal has been a reliable resource for a wide audience of clinical researchers, epidemiologists, immunologists, and cell biologists interested in breast cancer.
  • With 800K+ article downloads each year, the journal provides a high visibility platform for your research.
  • We create a “market place” for breast cancer topics, with international editorial board from world-class centres determining the best articles from authors worldwide.
  • We provide high levels of author satisfaction, with 93% of our reporting that they would definitely or probably publish with us again.

Recommended Reading: What Are The Odds Of Getting Breast Cancer

Breast Cancer Research And Treatment H

Breast Cancer Research and Treatment has an h-index of 160. It means 160 articles of this journal have more than 160 number of citations.The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.

Burgundian Habsburg And Spanish Habsburg Netherlands

Most of the and fiefs in what is now the Netherlands and Belgium were united in a by Philip the Good, Duke of , in 1433. The and their heirs would rule the Low Countries in the period from 1384 to 1581. Before the Burgundian union, the Dutch identified themselves by the town they lived in or their local duchy or county. The Burgundian period is when the road to nationhood began. The new rulers defended Dutch trading interests, which then developed rapidly. The fleets of the defeated the fleets of the several times. grew and in the 15th century became the primary trading port in Europe for grain from the . Amsterdam distributed grain to the major cities of Belgium, Northern France and England. This trade was vital because Holland could no longer produce enough grain to feed itself. Land drainage had caused the of the former to reduce to a level that was too low for drainage to be maintained.

Under Habsburg , ruler of the and King of , all fiefs in the current Netherlands region were united into the , which also included most of present-day Belgium, Luxembourg, and some adjacent land in what is now France and Germany. In 1568, under Phillip II, the between the Provinces and their ruler began. The level of ferocity exhibited by both sides can be gleaned from a Dutch chronicler’s report:

Don’t Miss: What Is De Novo Metastatic Breast Cancer

RELATED ARTICLES

Popular Articles